<DOC>
	<DOCNO>NCT01138722</DOCNO>
	<brief_summary>Surgical resection mediastinal lymph node sample currently therapy choice early stage ( I-II ) non-small cell lung cancer ( NSCLC ) . Selected patient unwilling unable tolerate surgery refer so-called 'curative ' high dose radiotherapy . This show result long term local disease control rate high cancer specific survival . The current trial address relationship blood tissue biomarkers , bio-imaging pathology patient early stage NSCLC treat hypofractionated radiation therapy surgery .</brief_summary>
	<brief_title>Predicting Cell Death Radiation Therapy Early Stage Non-small Cell Lung Cancer : Prospective Translational Trial</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Proof cT1a/b 2a/b N0M0 NSCLC Informed Consent sign Resectable tumour Operable patient &gt; 18 year old men woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>early stage non-small cell lung cancer</keyword>
	<keyword>hypofractionated radiation therapy</keyword>
</DOC>